Jayson D.A. Dallas
2019
In 2019, Jayson D.A. Dallas earned a total compensation of $4.7M as Chief Executive Officer at Aimmune Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Bonus | $10,350 |
|---|---|
| Non-Equity Incentive Plan | $357,075 |
| Option Awards | $2,969,484 |
| Salary | $575,000 |
| Stock Awards | $830,200 |
| Other | $2,000 |
| Total | $4,744,109 |
Dallas received $3M in option awards, accounting for 63% of the total pay in 2019.
Dallas also received $10.4K in bonus, $357.1K in non-equity incentive plan, $575K in salary, $830.2K in stock awards and $2K in other compensation.
Rankings
In 2019, Jayson D.A. Dallas' compensation ranked 2,370th out of 13,971 executives tracked by ExecPay. In other words, Dallas earned more than 83.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,370 out of 13,971 | 83rd |
Division Manufacturing | 856 out of 5,701 | 85th |
Major group Chemicals And Allied Products | 275 out of 2,200 | 88th |
Industry group Drugs | 220 out of 1,886 | 88th |
Industry Pharmaceutical Preparations | 161 out of 1,398 | 89th |
Source: SEC filing on April 9, 2020.
Dallas' colleagues
We found four more compensation records of executives who worked with Jayson D.A. Dallas at Aimmune Therapeutics in 2019.